Intensive glucose lowering and cardiovascular disease prevention in diabetes: reconciling the recent clinical trial data.
about
Intensive versus conventional glycaemic control for treating diabetic foot ulcersIntensive versus conventional glycaemic control for treating diabetic foot ulcersOxytocin and cardioprotection in diabetes and obesityInsulin resistance, hyperglycemia, and atherosclerosisDiagnostic approaches for diabetic cardiomyopathy.High glucose induced oxidative stress and apoptosis in cardiac microvascular endothelial cells are regulated by FoxO3a.Targeting metabolic disturbance in the diabetic heart.Updating experimental models of diabetic cardiomyopathyParadoxical effects of streptozotocin-induced diabetes on endothelial dysfunction in stroke-prone spontaneously hypertensive rats.C1q-TNF-related protein-9, a novel cardioprotetcive cardiokine, requires proteolytic cleavage to generate a biologically active globular domain isoform.Pharmacological inhibition of soluble epoxide hydrolase provides cardioprotection in hyperglycemic rats.Diabetes mellitus and the risk of gastric cancer: a meta-analysis of cohort studiesGlucagon-like peptide-1 protects against cardiac microvascular injury in diabetes via a cAMP/PKA/Rho-dependent mechanism.Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical ConsiderationsDoes Glucagon-like Peptide-1 Ameliorate Oxidative Stress in Diabetes? Evidence Based on Experimental and Clinical Studies.Intensive glucose control and hypoglycaemia: a new cardiovascular risk factor?Autophagy inhibits high glucose induced cardiac microvascular endothelial cells apoptosis by mTOR signal pathway.Osteoprotegerin as a marker of cardiovascular risk in children and adolescents with type 1 diabetes.Is vitamin D deficiency related to accumulation of advanced glycation end products, markers of inflammation, and oxidative stress in diabetic subjects?Combined Interval Training and Post-exercise Nutrition in Type 2 Diabetes: A Randomized Control Trial.Hyperglycemia accelerates ATP-binding cassette transporter A1 degradation via an ERK-dependent pathway in macrophages.Sitagliptin improved glucose assimilation in detriment of fatty-acid utilization in experimental type-II diabetes: role of GLP-1 isoforms in Glut4 receptor trafficking.Sugar makes neutrophils RAGE: linking diabetes-associated hyperglycemia to thrombocytosis and platelet reactivity.Open-label randomized non-inferiority trial of a fixed-dose combination of glimepiride and atorvastatin for the treatment of people whose Type 2 diabetes is uncontrolled on metformin.Triterpene alcohols and sterols from rice bran reduce postprandial hyperglycemia in rodents and humansGLP-1 treatment protects endothelial cells from oxidative stress-induced autophagy and endothelial dysfunction
P2860
Q24186487-A8311D93-24A7-4F93-86D7-CA8954DA3AB6Q24197832-7D044525-4F4B-46BE-8EC1-9DBDA03EF108Q26748592-58537C54-17C7-46C1-B548-75A7D9639346Q27011696-2E5F9548-EE7D-437F-A7CD-B56A7D38739CQ30362092-F58EC403-3552-4D15-8E21-26B373E472B3Q35048692-9BD0A896-3243-4581-A075-C9417044CFA3Q35084845-8C5053D2-7DE3-4A45-B3CB-0CFABB319C9EQ35564129-0F81FB8B-0457-4049-83A0-ED77EC5B7F66Q35577511-AA11403C-0C6E-4038-9F04-023F57F484F0Q35622442-80C9D4BE-276C-4CE6-BFD3-3CF20B93940DQ36312752-F218A1F1-35C1-4F56-8BF3-96540C7DB2ADQ36348876-CB93F0F3-B4CE-43AC-AD59-7A9106433772Q36796024-CA024E5B-AA7E-41C3-8CC8-4975E1882D18Q37011769-BBE17E49-11AC-4D7F-82EA-DBC5D2D1C8ABQ37402790-B8A0F9F5-0724-4F5C-AC4C-C07DA71B6193Q38108643-E542CBC0-DD88-4BE2-9FAD-F84C0B0A51BFQ38616472-7A550AB7-DF3D-4D27-B51D-2812FA219FDAQ39824391-761FC424-3E9E-4FEF-98CF-30701C9EC684Q40519859-1CA3F67F-DEB1-44ED-8236-F443DE15432FQ41108908-BD7C21C3-BE2B-4F51-B2E4-BEB048ECBB21Q46982145-37A3C5E0-0274-448C-9CAB-B76FDE26CFF1Q48043450-4505A662-EC5F-49D2-AC01-50918335AF1DQ51001666-1400D540-3C59-494C-9452-69B324729BD0Q51295262-7BA6919E-A6BC-458E-A493-2A287EE456EDQ57266921-275C6F00-5C8D-4257-9DB2-85ACA469DB05Q58757970-FE8CE6BB-B806-4E0E-9AFD-F42C3763CD5A
P2860
Intensive glucose lowering and cardiovascular disease prevention in diabetes: reconciling the recent clinical trial data.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Intensive glucose lowering and ...... he recent clinical trial data.
@ast
Intensive glucose lowering and ...... he recent clinical trial data.
@en
type
label
Intensive glucose lowering and ...... he recent clinical trial data.
@ast
Intensive glucose lowering and ...... he recent clinical trial data.
@en
prefLabel
Intensive glucose lowering and ...... he recent clinical trial data.
@ast
Intensive glucose lowering and ...... he recent clinical trial data.
@en
P2860
P1433
P1476
Intensive glucose lowering and ...... he recent clinical trial data.
@en
P2093
Theodore Mazzone
P2860
P304
P356
10.1161/CIRCULATIONAHA.109.913350
P407
P577
2010-11-01T00:00:00Z